Literature DB >> 12880391

The annual cost of blood transfusions in the UK.

S J Varney1, J F Guest.   

Abstract

This study estimated the annual UK cost of blood transfusions in 2000/2001, updating a study we performed in 1994/1995. The analysis was based on published data, information from interviews with National Health Service (NHS) personnel and a structured questionnaire for blood donors. The annual cost of provision and transfusion of blood products increased by 256% in real terms, to pounds 898 million in 2000/2001, whereas the number of whole-blood donations increased by 2% to 2.8 million. The number of apheresis donations decreased by 52% to 70 000. Total blood product units issued to hospitals in 2000/2001 increased by 17% and were used in an estimated 1.7 million transfusions. The estimated NHS cost for an adult transfusion was pounds 635 for red blood cells, pounds 378 for fresh frozen plasma, pounds 347 for platelets and pounds 834 for cryoprecipitate. Blood donors incurred an annual direct cost of pounds 8.1 million and 3.1 million hours of used leisure time. There was also an indirect cost of pounds 7.2 million arising from lost productivity. The large increases since 1994/1995 reflect a real increase in expenditure by the blood transfusion services, partly due to the introduction of leucodepletion, greater hospital resource use due to more transfusions being undertaken and under-recording of hospital activity in 1994/1995.

Mesh:

Year:  2003        PMID: 12880391     DOI: 10.1046/j.1365-3148.2003.00443.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  30 in total

1.  Transfusion drains versus suction drains in total knee replacement: meta-analysis.

Authors:  Sheraz R Markar; Gareth G Jones; Alan Karthikesalingam; Nicholas Segaren; Rahul V Patel
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-10       Impact factor: 4.342

Review 2.  Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials.

Authors:  Zhi-Jun Li; Xin Fu; Dan Xing; Hua-Feng Zhang; Jia-Cheng Zang; Xin-Long Ma
Journal:  Eur Spine J       Date:  2013-05-09       Impact factor: 3.134

3.  Alternative procedures for reducing allogeneic blood transfusion in elective orthopedic surgery.

Authors:  Kathrin Kleinert; Oliver M Theusinger; Johannes Nuernberg; Clément M L Werner
Journal:  HSS J       Date:  2010-01-28

4.  Fibrin sealant before wound closure in total knee arthroplasty reduced blood loss: a meta-analysis.

Authors:  Zhi-Jun Li; Xin Fu; Peng Tian; Wen-Xing Liu; Yao-Min Li; Yong-Fa Zheng; Xin-Long Ma; Wei-Min Deng
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-12       Impact factor: 4.342

5.  Survey on blood ordering and utilisation patterns in elective urological surgery.

Authors:  Hossein Khoshrang; Ali Hamidi Madani; Zahra Atarkar Roshan; Maryam Soltani Ramezanzadeh
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

6.  Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system.

Authors:  K Le Lay; E Myon; S Hill; L Riou-Franca; D Scott; M Sidhu; D Dunlop; R Launois
Journal:  Eur J Health Econ       Date:  2007-02-28

7.  Cost-utility analysis of survival with epoetin-alfa versus placebo in stage IV breast cancer.

Authors:  Silas C Martin; Dennis D Gagnon; Lucy Zhang; Carsten Bokemeyer; Marinus Van Marwijk Kooy; Ben van Hout
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Reducing unnecessary preoperative blood orders and costs by implementing an updated institution-specific maximum surgical blood order schedule and a remote electronic blood release system.

Authors:  Steven M Frank; Michael J Oleyar; Paul M Ness; Aaron A R Tobian
Journal:  Anesthesiology       Date:  2014-09       Impact factor: 7.892

9.  Improved short-term survival with polyethylene glycol modified hemoglobin liposomes in critical normovolemic anemia.

Authors:  Andreas Pape; Harry Kertscho; Jens Meier; Oliver Horn; Mohamed Laout; Max Steche; Mischa Lossen; Alf Theisen; Bernhard Zwissler; Oliver Habler
Journal:  Intensive Care Med       Date:  2008-04-02       Impact factor: 17.440

10.  Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.

Authors:  Nigel Armstrong; Nasuh Büyükkaramikli; Hannah Penton; Rob Riemsma; Pim Wetzelaer; Vanesa Huertas Carrera; Stephanie Swift; Thea Drachen; Heike Raatz; Steve Ryder; Dhwani Shah; Titas Buksnys; Gill Worthy; Steven Duffy; Maiwenn Al; Jos Kleijnen
Journal:  Health Technol Assess       Date:  2020-10       Impact factor: 4.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.